The main theme of the report is the analysis of the state and prospects of the MedTech industry by 2025.
Key findings include: continued revenue growth reaching $584 billion, a 20% increase in venture investments in the sector, and average funding rounds and M&A deals significantly exceeding the averages of the past five years. Despite global economic and political challenges, the MedTech industry continues to successfully innovate and commercialize. The impact of new trade conditions and tariffs on the industry will be less significant than expected. A group of leaders is emerging, focusing their strategic investments on innovation and high-growth potential markets.